Brown Advisory Inc. Reduces Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Brown Advisory Inc. lessened its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 3.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,822,615 shares of the company's stock after selling 192,227 shares during the quarter. Brown Advisory Inc. owned about 1.51% of LifeStance Health Group worth $38,779,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Teacher Retirement System of Texas bought a new stake in LifeStance Health Group during the 1st quarter valued at approximately $130,000. Smithbridge Asset Management Inc. DE bought a new stake in LifeStance Health Group during the 1st quarter valued at approximately $563,000. Summit Global Investments bought a new stake in LifeStance Health Group during the 1st quarter valued at approximately $241,000. Wellington Management Group LLP raised its stake in LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock valued at $38,886,000 after purchasing an additional 445,796 shares during the period. Finally, Forum Financial Management LP bought a new stake in LifeStance Health Group during the 4th quarter valued at approximately $110,000. Institutional investors own 85.50% of the company's stock.

Analyst Ratings Changes

LFST has been the topic of several recent analyst reports. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a research note on Tuesday, May 27th. KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target for the company. Finally, Canaccord Genuity Group initiated coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target for the company. One equities research analyst has rated the stock with a sell rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $8.50.

LifeStance Health Group Trading Down 4.7%

Shares of LifeStance Health Group stock traded down $0.22 on Friday, reaching $4.51. The company had a trading volume of 3,464,434 shares, compared to its average volume of 1,691,510. The firm has a market cap of $1.75 billion, a price-to-earnings ratio of -45.10 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. The firm's 50-day moving average price is $5.45 and its two-hundred day moving average price is $6.68. LifeStance Health Group, Inc. has a 1 year low of $4.47 and a 1 year high of $8.61.

Insider Activity at LifeStance Health Group

In other news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total value of $95,040.00. Following the completion of the transaction, the insider owned 113,435 shares in the company, valued at approximately $673,803.90. The trade was a 12.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 3.20% of the company's stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.